Compare Abeona Therapeutics Inc (ABEO) vs Axogen Inc (AXGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs Axogen Inc — how do they compare? Abeona Therapeutics Inc trades at $7.34 (market cap $421.19M), while Axogen Inc trades at $48.5 (market cap $2.61B). The key difference: Axogen Inc is far larger — about 6.2× Abeona Therapeutics Inc's market cap. Which is the better fit depends on your goals.
| ABEO | AXGN | |
|---|---|---|
Market Cap | $421.19M | $2.61B |
Sector | Health | Technology |
52-Week High | $7.45 | $48.48 |
52-Week Low | $4.17 | $14.16 |
Enterprise Value | $276.10M | $2.52B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Axogen Inc
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →
